Log In
Print
BCIQ
Print
Print this Print this
 

INT-767

  Manage Alerts
Collapse Summary General Information
Company Intercept Pharmaceuticals Inc.
DescriptionFarnesoid X receptor (FXR; NR1H4) and G protein-coupled bile acid receptor 1 (GPBAR1; TGR5) agonist
Molecular Target Farnesoid X receptor (FXR) (NR1H4) ; G protein-coupled bile acid receptor 1 (GPBAR1) (TGR5)
Mechanism of ActionFarnesoid X receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Renal (unspecified)
Indication DetailsTreat chronic kidney disease (CKD) associated with diabetic nephropathy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today